UCB Governance

The Company is administered by a Board of Directors and run by an Executive Committee, whose respective functions and responsibilities are clearly defined in the Corporate Governance Charter.

 

Board of Directors

As at 1 January 2026, the Board will be:

  • 15 Members
  • 10 Independent Directors (66.7%)
  • 8 Nationalities
  • 6 Women (40%)
  • 4-Year Mandate
  • Age Limit: 70

Board of Directors

the Audit Committee

The Audit Committee assists the Board in its responsibility of monitoring the management of UCB and the UCB Group as a whole.

3 members (67% independent):

  • Rodolfo J. Savitzky (Chair & Independent Director)
  • Maëlys Castella (Independent Director)
  • Cédric van Rijckevorsel (Director)

the Governance, Remuneration and Nomination Committee (GNCC)

The Governance, Remuneration and Nomination Committee (GNCC) ensures that the appointment and re-election process is organized objectively and professionally and proposes the remuneration policy for non-executive Directors and executive managers.

5 members (80% independent):

  • Kay Davies (Chair & Independent Director)
  • Charles-Antoine Janssen (Director)
  • Pierre Gurdjian (Independent Director)
  • Nefertiti Greene (Independent Director)
  • Ulf Wiinberg (Independent Director)

the Scientific Committee

The Scientific Committee assists the Board when reviewing the quality of UCB’s R&D science and its competitive standing. It assesses the strategy proposed by UCB’s management in R&D matters and communicates its recommendations to the Board.

4 members (75% independent):

  • Kay Davies (Independent Director)
  • Dolca Thomas (Independent Director)
  • Stef Heylen (Director)
  • Fiona Powrie (Independent Director)

 

Composition of the Board of Directors

 

Composition of the Executive Committee